TriSalus Life Sciences's total assets for Q4 2024 were $23.97M, a decrease of -12.76% from the previous quarter. TLSI total liabilities were $49.87M for the fiscal quarter, a 4.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.